Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 — Raleigh, North Carolina

Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 is a clinical research site located in Raleigh, North Carolina, United States 27609.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Meningitis.

Sponsors: Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Raleigh

Browse all research sites in North Carolina · View every site in Raleigh

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200?

Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 conducted?

Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 has 1 clinical trials on record. Their work covers Meningococcal Meningitis.

Is Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 accredited by Crixeo Clinical Trials?

Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capitol Pediatrics and Adolescent Center, 3801 Computer Drive Suite 200?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.